XLV Health Care Select Sector SPDR
- Health & Biotech Equities
XLV - Profile
- Issuer: State Street SPDR
- Structure: ETF
- Expense Ratio: 0.15%
- ETF Home Page: XLV
- Inception: Dec 16, 1998
- Tax Form: 1099
- XLV Tracks This Index: Health Care Select Sector Index
- 52 Week Lo: $57.42
- 52 Week Hi: $76.01
- AUM: $14,326.5 M
- Shares: 190.7 M
Alternative ETFs in the Health & Biotech Equities Category
|Type||Ticker||Expense Ratio||Assets||Avg. Daily Vol||YTD Return|
|Most Liquid (Volume)|
|Top YTD Performer|
The Health Care Select Sector Index includes companies from the following industries: pharmaceuticals; health care providers & services; health care equipment & supplies; biotechnology; life sciences tools & services; and health care technology.
XLV - Realtime Rating
Realtime Rating Summary
XLV is a passive ETF that seeks to replicate Health Care Select Sector Index. The Health Care Select Sector Index includes companies from the following industries: pharmaceuticals; health care providers & services; health care equipment & supplies; biotechnology; life sciences tools & services; and health care technology.
The adjacent table gives investors an individual Realtime Rating for XLV on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.
XLV In-Depth Analysis
The following tables and charts contain in-depth metrics for XLV and compare it to similar peer ETFs within its ETFdb Category.
XLV - HoldingsFilings Data as of: May 04, 2015
Top Ten Holdings
This section compares how balanced and deep XLV is relative to the peer group ETFdb Category.
XLV Asset Allocation
XLV Sector Breakdown
XLV Market Cap Breakdown
XLV Region Breakdown
XLV Market Tier Breakdown
XLV Country Breakdown
XLV - Expenses & Fees
This section compares the cost efficiency of XLV to peers in the same ETFdb Category.
Expenses Ratio Analysis
Commission Free Trading in XLV
XLV is not currently available for commission free trading on any platforms.
Category Commission Free Trading
There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:
XLV - Performance
This section shows how XLV has performed relative to its peer group ETFdb Category.
XLV - Charts
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of XLV relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
XLV - Technicals
XLV Volatility Analysis
This section shows how the volatility of XLV compares to the peer group ETFdb Category.
- 20 Day MA: $73.45
- 60 Day MA: $73.13
- MACD 15 Period: 1.58
- MACD 100 Period: 3.26
- Williams % Range 10 Day: 11.11
- Williams % Range 20 Day: 7.49
- RSI 10 Day: 68
- RSI 20 Day: 60
- RSI 30 Day: 58
- Ultimate Oscillator: 64
XLV Bollinger Bands
- Lower Bollinger (10 Day): $72.56
- Upper Bollinger (10 Day): $75.64
- Lower Bollinger (20 Day): $71.46
- Upper Bollinger (20 Day): $75.43
- Lower Bollinger (30 Day): $71.88
- Upper Bollinger (30 Day): $75.34
XLV Support & Resistance
- Support Level 1: n/a
- Support Level 2: $74.73
- Resistance Level 1: n/a
- Resistance Level 2: $75.45
- Stochastic Oscillator %D (1 Day): 67.80
- Stochastic Oscillator %D (5 Day): 84.64
- Stochastic Oscillator %K (1 Day): 64.49
- Stochastic Oscillator %K (5 Day): 83.63
Latest XLV News
Sector SPDRs: How These ETFs Have Performed Since Inception
How to Spot a Sector Rotation with ETFs
Buy On The Dip Prospects April 7th Edition
2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.